The funds’ strategy is to invest in EIS qualifying companies involved in the development, commercialisation and sale of innovative technologies or services or use them to gain a competitive advantage.
Strategy: Exposure to a portfolio of early start-up or early stage technology companies
Portfolio Risk: Early stage companies carry significant risk, though Symvan have had no failures to date.
Team: Symvan bring a broad range of capital markets experience and a focus on a company’s funding needs throughout its investment period.
Depth of Staff: The Symvan team is very small, though has very experienced advisors and only a few companies to manage.